Aug 25 (Reuters) - MannKind Corp MNKD.O:
MANNKIND TO ACQUIRE SCPHARMACEUTICALS, ACCELERATING REVENUE GROWTH AND EMERGING AS A PATIENT-CENTRIC LEADER IN CARDIOMETABOLIC AND LUNG DISEASES
MANNKIND CORP - DEAL FOR UPFRONT CASH PAYMENT OF $5.35 PER SHARE PLUS CVR
MANNKIND CORP - TOTAL EQUITY VALUE $303 MILLION, DEAL VALUE UP TO $360 MILLION
MANNKIND CORP - CO AND BLACKSTONE AMEND FINANCING AGREEMENT FOR $175 MILLION